160 related articles for article (PubMed ID: 21076535)
1. Use of ultra high performance liquid chromatography-tandem mass spectrometry to demonstrate decreased serum statin levels after extracorporeal LDL-cholesterol elimination.
Bláha M; Vlcková H; Nováková L; Solichová D; Solich P; Lánská M; Malý J; Bláha V
J Biomed Biotechnol; 2011; 2011():912472. PubMed ID: 21076535
[TBL] [Abstract][Full Text] [Related]
2. Ultra high performance liquid chromatography tandem mass spectrometric detection in clinical analysis of simvastatin and atorvastatin.
Nováková L; Vlcková H; Satínský D; Sadílek P; Solichová D; Bláha M; Bláha V; Solich P
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):2093-103. PubMed ID: 19540175
[TBL] [Abstract][Full Text] [Related]
3. Influence of atorvastatin versus simvastatin on fibrinogen and other hemorheological parameters in patients with severe hypercholesterolemia treated with regular low-density lipoprotein immunoadsorption apheresis.
Otto C; Geiss HC; Donner MG; Parhofer KG; Schwandt P
Ther Apher; 2000 Jun; 4(3):244-8. PubMed ID: 10910028
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different treatment regimens in a case of homozygous familial hypercholesterolemia.
Palcoux JB; Meyer M; Jouanel P; Vanlieferinghen P; Malpuech G
Ther Apher; 2002 Apr; 6(2):136-9. PubMed ID: 11982954
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.
Gagné C; Gaudet D; Bruckert E;
Circulation; 2002 May; 105(21):2469-75. PubMed ID: 12034651
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia.
Goldammer A; Wiltschnig S; Heinz G; Jansen M; Stulnig T; Hörl WH; Derfler K
Metabolism; 2002 Aug; 51(8):976-80. PubMed ID: 12145769
[TBL] [Abstract][Full Text] [Related]
7. The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy.
Yamamoto A; Harada-Shiba M; Kawaguchi A; Oi K; Kubo H; Sakai S; Mikami Y; Imai T; Ito T; Kato H; Endo M; Sato I; Suzuki Y; Hori H
Atherosclerosis; 2000 Nov; 153(1):89-98. PubMed ID: 11058703
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome.
Hunninghake DB; Ballantyne CM; Maccubbin DL; Shah AK; Gumbiner B; Mitchel YB
Clin Ther; 2003 Jun; 25(6):1670-86. PubMed ID: 12860491
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia.
Schmaldienst S; Banyai S; Stulnig TM; Heinz G; Jansen M; Hörl WH; Derfler K
Atherosclerosis; 2000 Aug; 151(2):493-9. PubMed ID: 10924726
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a sensitive, simple, and rapid method for simultaneous quantitation of atorvastatin and its acid and lactone metabolites by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Macwan JS; Ionita IA; Dostalek M; Akhlaghi F
Anal Bioanal Chem; 2011 Apr; 400(2):423-33. PubMed ID: 21359569
[TBL] [Abstract][Full Text] [Related]
11. Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia.
van Tits LJ; Smilde TJ; van Wissen S; de Graaf J; Kastelein JJ; Stalenhoef AF
J Investig Med; 2004 Apr; 52(3):177-84. PubMed ID: 15222407
[TBL] [Abstract][Full Text] [Related]
12. The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy.
Yamamoto A; Harada-Shiba M; Endo M; Kusakabe N; Tanioka T; Kato H; Shoji T
Atherosclerosis; 2006 May; 186(1):126-31. PubMed ID: 16043185
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of simvastatin, lovastatin, atorvastatin, and their major metabolites in human plasma.
Wang J; Luzum JA; Phelps MA; Kitzmiller JP
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 983-984():18-25. PubMed ID: 25612772
[TBL] [Abstract][Full Text] [Related]
14. Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia.
Marais AD; Naoumova RP; Firth JC; Penny C; Neuwirth CK; Thompson GR
J Lipid Res; 1997 Oct; 38(10):2071-8. PubMed ID: 9374129
[TBL] [Abstract][Full Text] [Related]
15. A case of familial hypercholesterolemia; secession from LDL-apheresis by the drug treatment with potent statin and resin.
Shiina Y; Homma Y; Oguma T; Fusegawa Y; Ozawa H; Handa S; Tanabe T
Tokai J Exp Clin Med; 2005 Sep; 30(3):149-55. PubMed ID: 16285605
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin compared with simvastatin in patients with severe LDL hypercholesterolaemia treated by regular LDL apheresis.
Geiss HC; Parhofer KG; Schwandt P
J Intern Med; 1999 Jan; 245(1):47-55. PubMed ID: 10095816
[TBL] [Abstract][Full Text] [Related]
17. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial.
Päivä H; Thelen KM; Van Coster R; Smet J; De Paepe B; Mattila KM; Laakso J; Lehtimäki T; von Bergmann K; Lütjohann D; Laaksonen R
Clin Pharmacol Ther; 2005 Jul; 78(1):60-8. PubMed ID: 16003294
[TBL] [Abstract][Full Text] [Related]
18. Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia.
van Wissen S; Smilde TJ; Trip MD; de Boo T; Kastelein JJ; Stalenhoef AF
Heart; 2003 Aug; 89(8):893-6. PubMed ID: 12860867
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of statin therapy: possible effect of phenytoin.
Murphy MJ; Dominiczak MH
Postgrad Med J; 1999 Jun; 75(884):359-60. PubMed ID: 10435174
[TBL] [Abstract][Full Text] [Related]
20. A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.
Olsson AG; Eriksson M; Johnson O; Kjellström T; Lanke J; Larsen ML; Pedersen T; Tikkanen MJ; Wiklund O;
Clin Ther; 2003 Jan; 25(1):119-38. PubMed ID: 12637115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
